172 related articles for article (PubMed ID: 36536520)
21. Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity.
Hartmann JS; Thompson H; Wang H; Kanekar S; Huang W; Budd SJ; Hartnett ME
Mol Vis; 2011; 17():1577-87. PubMed ID: 21738387
[TBL] [Abstract][Full Text] [Related]
22. Adenosine receptors and caffeine in retinopathy of prematurity.
Chen JF; Zhang S; Zhou R; Lin Z; Cai X; Lin J; Huo Y; Liu X
Mol Aspects Med; 2017 Jun; 55():118-125. PubMed ID: 28088487
[TBL] [Abstract][Full Text] [Related]
23. β‑elemene inhibits oxygen‑induced retinal neovascularization via promoting miR‑27a and reducing VEGF expression.
Zhang W; Chen L; Geng J; Liu L; Xu L
Mol Med Rep; 2019 Mar; 19(3):2307-2316. PubMed ID: 30664207
[TBL] [Abstract][Full Text] [Related]
24. Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.
Wang W; LeBlanc ME; Chen X; Chen P; Ji Y; Brewer M; Tian H; Spring SR; Webster KA; Li W
Angiogenesis; 2017 Nov; 20(4):479-492. PubMed ID: 28447229
[TBL] [Abstract][Full Text] [Related]
25. The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease.
Sidman RL; Li J; Lawrence M; Hu W; Musso GF; Giordano RJ; Cardó-Vila M; Pasqualini R; Arap W
Sci Transl Med; 2015 Oct; 7(309):309ra165. PubMed ID: 26468327
[TBL] [Abstract][Full Text] [Related]
26. Altered retinal microRNA expression profiles in early diabetic retinopathy: an in silico analysis.
Xiong F; Du X; Hu J; Li T; Du S; Wu Q
Curr Eye Res; 2014 Jul; 39(7):720-9. PubMed ID: 24502381
[TBL] [Abstract][Full Text] [Related]
27. The effects of microRNAs in activating neovascularization pathways in diabetic retinopathy.
Satari M; Aghadavod E; Mirhosseini N; Asemi Z
J Cell Biochem; 2019 Jun; 120(6):9514-9521. PubMed ID: 30556195
[TBL] [Abstract][Full Text] [Related]
28. Identification of potential molecular targets associated with proliferative diabetic retinopathy.
Shao D; He S; Ye Z; Zhu X; Sun W; Fu W; Ma T; Li Z
BMC Ophthalmol; 2020 Apr; 20(1):143. PubMed ID: 32290826
[TBL] [Abstract][Full Text] [Related]
29. ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases.
Gong Y; Fu Z; Liegl R; Chen J; Hellström A; Smith LE
Am J Clin Nutr; 2017 Jul; 106(1):16-26. PubMed ID: 28515072
[TBL] [Abstract][Full Text] [Related]
30. Absence of macrophage migration inhibitory factor reduces proliferative retinopathy in a mouse model.
Wang J; Lin J; Kaiser U; Wohlfart P; Hammes HP
Acta Diabetol; 2017 Apr; 54(4):383-392. PubMed ID: 28070752
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-409-5p promotes retinal neovascularization in diabetic retinopathy.
Wang Y; Lin W; Ju J
Cell Cycle; 2020 Jun; 19(11):1314-1325. PubMed ID: 32292119
[TBL] [Abstract][Full Text] [Related]
32. Thrombocytopenia is associated with severe retinopathy of prematurity.
Cakir B; Liegl R; Hellgren G; Lundgren P; Sun Y; Klevebro S; Löfqvist C; Mannheimer C; Cho S; Poblete A; Duran R; Hallberg B; Canas J; Lorenz V; Liu ZJ; Sola-Visner MC; Smith LE; Hellström A
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282834
[TBL] [Abstract][Full Text] [Related]
33. MiR-375 mitigates retinal angiogenesis by depressing the JAK2/STAT3 pathway.
Gong R; Han R; Zhuang X; Tang W; Xu G; Zhang L; Wu J; Ma J
Aging (Albany NY); 2022 Aug; 14(16):6594-6604. PubMed ID: 35980290
[TBL] [Abstract][Full Text] [Related]
34. Astragalus root extract inhibits retinal cell apoptosis and repairs damaged retinal neovascularization in retinopathy of prematurity.
Liu X; Wang B; Sun Y; Jia Y; Xu Z
Cell Cycle; 2019 Nov; 18(22):3147-3159. PubMed ID: 31564208
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-150 (miR-150) and Diabetic Retinopathy: Is miR-150 Only a Biomarker or Does It Contribute to Disease Progression?
Ko GY; Yu F; Bayless KJ; Ko ML
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292956
[TBL] [Abstract][Full Text] [Related]
36. New Aspects on the Treatment of Retinopathy of Prematurity: Currently Available Therapies and Emerging Novel Therapeutics.
Ryu J
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955664
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of vascular endothelial growth factor-induced retinal neovascularization by retinoic acid in experimental retinopathy of prematurity.
Ozkan H; Duman N; Kumral A; Kasap B; Ozer EA; Lebe B; Yaman A; Berk T; Yilmaz O; Ozer E
Physiol Res; 2006; 55(3):267-275. PubMed ID: 16083310
[TBL] [Abstract][Full Text] [Related]
38. Retinopathy of prematurity: contribution of inflammatory and genetic factors.
Fevereiro-Martins M; Guimarães H; Marques-Neves C; Bicho M
Mol Cell Biochem; 2022 Jun; 477(6):1739-1763. PubMed ID: 35262882
[TBL] [Abstract][Full Text] [Related]
39. [Pathogenesis of retinal neovascularization in a rat model of oxygen fluctuations-induced retinopathy].
Liu X; Wang W; Wang AR; Ning Q; Luo XP
Zhonghua Er Ke Za Zhi; 2007 Jan; 45(1):7-13. PubMed ID: 17349140
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of APE1/Ref-1 for Neovascular Eye Diseases: From Biology to Therapy.
Hartman GD; Lambert-Cheatham NA; Kelley MR; Corson TW
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
